AstraZeneca
AZN
$75.17
Share price
0.19%
Change (1 day)
2.06%
Change (1 year)
Categories
P/S ratio for AstraZeneca (AZN)
P/S ratio as of April 2024 (TTM): 5.09
According to AstraZeneca's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.08743. At the end of 2023 the company had a P/S ratio of 4.56.
P/S ratio history for AstraZeneca from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.56 | -3.93% |
| 2022 | 4.74 | -2.19% |
| 2021 | 4.85 | -1.45% |
| 2020 | 4.92 | -8.31% |
| 2019 | 5.37 | 25.56% |
| 2018 | 4.27 | 10.21% |
| 2017 | 3.88 | 29.36% |
| 2016 | 3.00 | -14.32% |
| 2015 | 3.50 | 3.59% |
| 2014 | 3.38 | 17.2% |
| 2013 | 2.88 | 37.53% |
| 2012 | 2.10 | 17.67% |
| 2011 | 1.78 | -8.96% |
| 2010 | 1.96 | -5.78% |
| 2009 | 2.08 | 10.47% |
| 2008 | 1.88 | -10.96% |
| 2007 | 2.11 | -31.88% |
| 2006 | 3.10 | -4.92% |
| 2005 | 3.26 | 16.72% |
| 2004 | 2.79 | -35.74% |
| 2003 | 4.35 | 27.15% |
| 2002 | 3.42 | -1.11% |
| 2001 | 3.46 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | -25.59% | 🇺🇸 USA |
 Novartis NVS | 3.90 | -23.39% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.46 | -51.69% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.65 | -8.58% | 🇺🇸 USA |
 Eli Lilly LLY | 20.4 | 301.19% | 🇺🇸 USA |
 Sanofi SNY | 2.44 | -52.05% | 🇫🇷 France |
 Biogen BIIB | 3.09 | -39.21% | 🇺🇸 USA |
 Merck MRK | 5.53 | 8.66% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.02 | -60.27% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.22 | -56.31% | 🇬🇧 UK |